MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer
Sung‐Hsin Kuo(National Taiwan University Hospital), Chiun‐Sheng Huang(National Taiwan University Hospital)
Cited by 17
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|799
Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
|Cancers|2019|42
Atorvastatin Attenuates Radiotherapy‐Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects
|Oxidative Medicine and Cellular Longevity|2022|15